Immunology of hepatitis B virus and hepatitis C virus infection

被引:1299
作者
Rehermann, B [1 ]
Nascimbeni, M [1 ]
机构
[1] NIDDKD, Liver Res Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1038/nri1573
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
More than 500 million people worldwide are persistently infected with the hepatitis B virus (HBV) and/or hepatitis C virus (HCV) and are at risk of developing chronic liver disease, cirrhosis and hepatocellular carcinoma. Despite many common features in the pathogenesis of HBV- and HCV-related liver disease, these viruses markedly differ in their virological properties and in their immune escape and survival strategies. This review assesses recent advances in our understanding of viral hepatitis, contrasts mechanisms of virus - host interaction in acute hepatitis B and hepatitis C, and outlines areas for future studies.
引用
收藏
页码:215 / 229
页数:15
相关论文
共 131 条
[41]  
FERRARI C, 1990, J IMMUNOL, V145, P3442
[42]   IKKε and TBK1 are essential components of the IRF3 signaling pathway [J].
Fitzgerald, KA ;
McWhirter, SM ;
Faia, KL ;
Rowe, DC ;
Latz, E ;
Golenbock, DT ;
Coyle, AJ ;
Liao, SM ;
Maniatis, T .
NATURE IMMUNOLOGY, 2003, 4 (05) :491-496
[43]   Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV [J].
Forns, X ;
Payette, PJ ;
Ma, XY ;
Satterfield, W ;
Eder, G ;
Mushahwar, IK ;
Govindarajan, S ;
Davis, HL ;
Emerson, SU ;
Purcell, RH ;
Bukh, J .
HEPATOLOGY, 2000, 32 (03) :618-625
[44]   Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease [J].
Foy, E ;
Li, K ;
Wang, CF ;
Sumpter, R ;
Ikeda, M ;
Lemon, SM ;
Gale, M .
SCIENCE, 2003, 300 (5622) :1145-1148
[45]   Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection:: exploring the immunological mechanisms [J].
Francavilla, V ;
Accapezzato, D ;
De Salvo, M ;
Rawson, P ;
Cosimi, O ;
Lipp, M ;
Cerino, A ;
Cividini, A ;
Mondelli, MU ;
Barnaba, V .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (02) :427-437
[46]  
Frasca L, 1999, J IMMUNOL, V163, P650
[47]   Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway [J].
Frese, M ;
Pietschmann, T ;
Moradpour, D ;
Haller, O ;
Bartenschlager, R .
JOURNAL OF GENERAL VIROLOGY, 2001, 82 :723-733
[48]   Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein [J].
Gale, MJ ;
Korth, MJ ;
Tang, NM ;
Tan, SL ;
Hopkins, DA ;
Dever, TE ;
Polyak, SJ ;
Gretch, DR ;
Katze, MG .
VIROLOGY, 1997, 230 (02) :217-227
[49]  
Ganem D., 2001, FIELDS VIROLOGY, V2, P2923
[50]   Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C [J].
Gerlach, JT ;
Diepolder, HM ;
Jung, MC ;
Gruener, NH ;
Schraut, WW ;
Zachoval, R ;
Hoffmann, R ;
Schirren, CA ;
Santantonio, T ;
Pape, GR .
GASTROENTEROLOGY, 1999, 117 (04) :933-941